Okay, let's tackle this question. The question is about diagnosing radiation-induced brain necrosis. First, I need to recall what imaging techniques are used for this condition.

Radiation necrosis typically occurs after treatment with radiation therapy, often for brain tumors. The core concept here is the imaging features that differentiate it from tumor recurrence. MRI is the primary tool.

On MRI, a key finding is a T2/FLAIR hyperintense lesion with a ring-enhancing pattern. But wait, how does that compare to tumor recurrence? Both can look similar, so other imaging modalities might help. Perfusion MRI can show decreased blood flow in necrosis compared to the increased flow in active tumors. Also, spectroscopy might show elevated lactate levels in necrosis.

Now, the options. Let's assume the choices are options like CT, X-ray, MRI, and maybe PET. The correct answer is MRI with specific sequences. Let me break down each option. CT might show hypodensity but isn't as specific. PET could show low metabolism in necrosis versus high in tumors. But MRI is the gold standard.

So the clinical pearl here is that distinguishing between necrosis and recurrence is crucial for management. Advanced MRI techniques are key. The correct answer should be MRI with contrast and specific sequences. Let me make sure each part of the explanation covers this without going over the character limit.

**Core Concept**
Radiation-induced brain necrosis is diagnosed using advanced neuroimaging to differentiate it from tumor recurrence. **Magnetic resonance imaging (MRI)** with contrast enhancement, **perfusion MRI**, and **magnetic resonance spectroscopy (MRS)** are critical for identifying necrotic tissue versus viable tumor. Key features include a "central vein sign" on MRI and decreased perfusion in necrosis compared to hyperperfusion in active tumors.

**Why the Correct Answer is Right**
**MRI with contrast** is the gold standard. Radiation necrosis typically presents as a **ring-enhancing lesion** with central hypointensity on T2/FLAIR sequences (central vein sign) and **hypoperfusion** on perfusion MRI. **MRS** shows elevated **lactate** and decreased **N-acetylaspartate (NAA)** in necrosis. These findings contrast with tumor recurrence, which shows hyperperfusion and increased NAA. Advanced MRI techniques help avoid unnecessary re-treatment.

**Why Each Wrong Option is Incorrect**
**Option A:** CT scan lacks specificity for distinguishing necrosis from tumor recurrence.
**Option B:** Plain X-ray is irrelevant for brain parenchymal lesions.
**Option C:** PET scan may show decreased metabolism in necrosis but is less specific without MRI correlation.

**Clinical Pearl / High-Yield Fact**
The "central vein sign" (central hypointensity within a ring-enhancing lesion on T2/FLAIR MRI) is pathognomonic for radiation necrosis. Always correlate perfusion and spectroscopy data with structural MRI to avoid misdiagnosis.

**Correct Answer: C. MRI with contrast and perfusion imaging**

✓ Correct Answer: A. PET scan